Search

everythinglearnresearchcommunity

for

Search:↓

A multidisciplinary approach is crucial for safe and effective hormone treatment in gender-dysphoric individuals, with specific guidelines for adolescents and adults.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.

Hormonal treatment in transgender women reduces semen quality, but stopping treatment may improve it.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

Oral estradiol works for many transgender women but needs personalized dosing and monitoring.

More research is needed to improve lower body gender affirmation techniques.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

DHT is crucial for urethral formation, and its disruption can affect masculinization and lead to hypospadias.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Hormone therapy and surgeries for transgender individuals affect their skin and hair, requiring specific dermatologic treatments and respectful care.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Finasteride effectively treats hair loss in transgender men with few side effects.

GnRH-a or orchiectomy is more effective than anti-androgens for managing hormone levels in transgender women.

Hormone therapy can improve mental health and quality of life for people with gender dysphoria, but long-term effects need more research.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Gender-affirming hormone therapy improves mental health and gender incongruence but requires careful management of cardiovascular and cancer risks.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Hair restoration helps transgender patients achieve desired gender appearances.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Gender-affirming dermatology treatments generally improve mental well-being for transgender individuals, but more research is needed.

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.